Publications by authors named "Thomas Systchenko"

Claim this Profile
T
Trends in the Incidence of Cancer Among Adolescents and Young Adults Between 2000 and 2020: A Study Based on French Population-Based Registry Data.
Emmanuel Desandes, Jacqueline Clavel, Florence Molinié, Patricia Delafosse, Brigitte Trétarre, Thomas Systchenko

J Adolesc Young Adult Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of synchronous and second primary malignancies in transplant-ineligible patients with multiple myeloma treated with lenalidomide.
Thomas Systchenko, Laly Nsiala, Arthur Bobin, Hélène Gardeney, Carine Motard

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More than two-thirds of patients with prostate cancer have the same or even a greater survival than the general male population: A French population-based study from Francim network of cancer registries.
Sébastien Lamy, Valérie Jooste, Cyrille Delpierre, Karima Hammas, Nicolas Vigneron, Thomas Systchenko

Fr J Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What are the sociodemographic characteristics of lung cancer patients travelling far to get surgery?
Alexandre Quillet, Nasreddine Khadraoui, Nicolas Isambert, Thomas Systchenko, Nolwenn Le Stang

Bull Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Representativeness of lung cancer patients: Differences between a population-based cancer registry and a university hospital].
Alexandre Quillet, Nicolas Isambert, Thomas Systchenko, Nolwenn Le Stang, Gautier Defossez

Bull Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of patients with accelerated and blast-phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination-A FIM study.
Corentin Orvain, Suzanne Tavitian, Clémence Mediavilla, Françoise Boyer, Alberto Santagostino, Thomas Systchenko

Hemasphere· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of the first immunocompromised patients to receive sipavibart as an early access treatment for COVID-19 pre-exposure prophylaxis in France.
Paul Loubet, Benjamin Gaborit, Mathilde Salpin, Hèlene Gardeney, Ilies Benotmane, Thomas Systchenko

Hum Vaccin Immunother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazine.
Antoine Machet, Caroline Poudou, Cécile Tomowiak, Thomas Gastinne, Martine Gardembas, Thomas Systchenko

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of azacitidine, venetoclax and ruxolitinib in blast phase myeloproliferative neoplasms.
Thomas Systchenko, Jean-Claude Chomel, Pilar Gallego-Hernanz, Niels Moya, Déborah Desmier

Br J Haematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hairy cell leukemia with isolated bone lesions.
Laura Cailly, Cécile Gruchet, Elsa Maitre, Stephanie Guidez, Vincent Delwail, Thomas Systchenko

Clin Case Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Waldenström macroglobulinemia and relationship to immune deficiency.
Anthony Levy, Stéphanie Guidez, Céline Debiais, Isabelle Princet, Sabrina Bouyer, Thomas Systchenko

Leuk Lymphoma· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Non-Immunologic Agents for Relapsed and Refractory Multiple Myeloma: A Review Article.
Arthur Bobin, Cécile Gruchet, Stéphanie Guidez, Hélène Gardeney, Laly Nsiala Makunza, Thomas Systchenko

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost and efficacy of peripheral stem cell mobilization strategies in multiple myeloma.
Zoé Van de Wyngaert, Virginie Nerich, Guillemette Fouquet, Marie-Lorraine Chrétien, Denis Caillot, Thomas Systchenko

Bone Marrow Transplant· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020.
Arthur Bobin, Evelyne Liuu, Niels Moya, Cécile Gruchet, Florence Sabirou, Thomas Systchenko

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study.
Emilie Cayssials, Jose Torregrosa-Diaz, Pilar Gallego-Hernanz, Florence Tartarin, Thomas Systchenko

Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to pneumococcal vaccination in multiple myeloma.
Loïc Renaud, Susanna Schraen, Guillemette Fouquet, Stephanie Guidez, Hélène Demarquette, Thomas Systchenko

Cancer Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteria.
Guillemette Fouquet, Kym Ie Snell, Stéphanie Guidez, Susanna Schraen, Eileen Boyle, Thomas Systchenko

Leuk Lymphoma· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis